Thomas Feiner, BCIA BCN QEEG-D’s Post

For those of you who have asked about upcoming training- here's an opportunity from EEG Learn. I hope you'll join me! Neurofeedback & DBR in Trauma Treatment with Sebern Fisher, MA, LMH, BCN Friday, September 8 - 1-2:30pm EDT 1 Innovative Session - $90 If you are eager to learn how Deep Brain Reorienting and Neurofeedback combined can provide transformative healing, then you will benefit from this webinar. Though neurofeedback is discussed there is no requirement to be trained in neurofeedback to enroll. You can expect to learn more about how to: Identify that fear circuitry begins in the brainstem Identify the core issue in developmental trauma as attachment failure or rupture Explain the attachment pattern that predicts “Borderline Personality” Utilize neurofeedback protocols that focus on the back of the brain Begin to explore Deep Brain Reorienting as a therapy synergistic with neurofeedback For more information and to enroll: https://lnkd.in/eRGMV5jU

Developing comprehensive treatments for 22q11.2DS requires an understanding of both the psychophysiological and neural mechanisms driving clinical outcomes" #22q Wesley Mulcahy https://lnkd.in/eBrxP_kX

Neuron transmission can help to understand psychological disorders.

While we further our citizen's science endorsed by Dr. Fadiman, I’ve gone over many research papers regarding the studies available up to date on the topic of micro-dosing psychedelics for therapeutic purposes. Considering that neuroplasticity plays a vital role in the therapeutic response of psychiatric patients, this study on the effects of micro-dosing LSD on BDNF levels in the brain has felt monumental for our cause. Within this study, it took as little as 5ug of LSD to significantly increase BDNF levels within just a 6-hour window. However, levels indicate that the peak of some doses could still be well after the 6-hour window, leaving much room for further studies of this revolutionary interaction. This increase in BDNF indicates significant benefits for improved neuroplasticity, showing us that LSD in low doses has a lot of therapeutic potential in treating mood-related disorders. For an interesting read in the psychedelic space, take a look at this study and let me know what you think about it. https://lnkd.in/erhiCZAU #microdosing #psychedelics #LSD #neuroplasticity #psychedelicscience #BDNF #neurogenesis #psychedelictherapy #DrJamesFadiman #ResetMicrodosingProgram

While we further our citizen's science endorsed by Dr. Fadiman, I’ve gone over many research papers regarding the studies available up to date on the topic of micro-dosing psychedelics for therapeutic purposes. Considering that neuroplasticity plays a vital role in the therapeutic response of psychiatric patients, this study on the effects of micro-dosing LSD on BDNF levels in the brain has felt monumental for our cause. Within this study, it took as little as 5ug of LSD to significantly increase BDNF levels within just a 6-hour window. However, levels indicate that the peak of some doses could still be well after the 6-hour window, leaving much room for further studies of this revolutionary interaction. This increase in BDNF indicates significant benefits for improved neuroplasticity, showing us that LSD in low doses has a lot of therapeutic potential in treating mood-related disorders. For an interesting read in the psychedelic space, take a look at this study and let me know what you think about it. https://lnkd.in/erhiCZAU #microdosing #psychedelics #LSD #neuroplasticity #psychedelicscience #BDNF #neurogenesis #psychedelictherapy #DrJamesFadiman #ResetMicrodosingProgram

Because of expanding interests in neurostimulation for various aspects like improving memory or relaxation, this science fiction book will be of interest to wide audiences. Specifically, the plot is centered on closed-loop (or feedback) Deep Brain Stimulation (DBS) and is in fact based in the same real life research performed in the laboratory of one of the authors. Dr. Jose Luis Perez Velazquez is a neuroscientist working on brain dynamics and the control of brain activity using electrical stimulation to alleviate epileptic seizures and compulsive reward-seeking behavior. But there are shortcomings with the current approach to DBS. There is a trial-and-error approach to developing DBS protocols that are being used in Parkinson’s disease, epilepsy, and addiction, without much consideration of the intrinsic brain activity and what may happen to brain function, as side effects. There are possible consequences of altered brain dynamics by neurostimulation in patients and this details the efforts of scientists, clinicians, and the police to fix the situation. The plight suffered in real life by psychiatric patients is described, and at the same time how neuroscience is changing criminal justice these days as the neuroscientific findings accumulate. Hence, the issue of moral responsibility arises in this neurotech field. Published 2020 #VIRTRA VirTra NATIONAL ALLIANCE ON MENTAL ILLNESS OF VERMONT INC #NAMI